Response to Hannah-Shmouni and Stratakis

Affiliations

¹ Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA. drstewart@mail.nih.gov.
² Department of Genetics, University of Alabama, Birmingham, Birmingham, AL, USA.
³ Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁵ Department of Pediatrics, Division of Medical Genetics, Stanford University School of Medicine, Palo Alto, CA, USA.
⁶ Department of Neurology, New York University School of Medicine, New York, NY, USA.

Free article

Comment

Douglas R Stewart et al. Genet Med. 2019 May.

Free article

. 2019 May;21(5):1256.

doi: 10.1038/s41436-018-0313-0. Epub 2018 Oct 4.

¹ Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA. drstewart@mail.nih.gov.
² Department of Genetics, University of Alabama, Birmingham, Birmingham, AL, USA.
³ Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁵ Department of Pediatrics, Division of Medical Genetics, Stanford University School of Medicine, Palo Alto, CA, USA.
⁶ Department of Neurology, New York University School of Medicine, New York, NY, USA.

No abstract available

Comment on

Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K. Stewart DR, et al. Genet Med. 2018 Jul;20(7):671-682. doi: 10.1038/gim.2018.28. Epub 2018 Apr 26. Genet Med. 2018. PMID: 30006586
Growth hormone excess in neurofibromatosis 1.
Hannah-Shmouni F, Stratakis CA. Hannah-Shmouni F, et al. Genet Med. 2019 May;21(5):1254-1255. doi: 10.1038/s41436-018-0312-1. Epub 2018 Oct 4. Genet Med. 2019. PMID: 30283094 No abstract available.

1. Hannah-Shmouni F, Stratakis CA. Growth hormone excess in neurofibromatosis type 1. Genet Med. 2018; https://doi.org/10.1038/s41436-018-0312-1
1. Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20:671–82. - DOI
1. Eugster E. Gigantism. In: De Groot LJ, Chrousos G, Dungan K, eds. Endotext. South Darmouth, MA: MDText.com; 2018. https://www.ncbi.nlm.nih.gov/books/NBK279155/
1. Josefson JL, Listernick R, Charrow J, Habiby RL. Growth hormone excess in children with optic pathway tumors is a transient phenomenon. Horm Res Paediatr. 2016;86:35–38. - DOI
1. Sani I, Albanese A. Endocrine long-term follow-up of children with neurofibromatosis type 1 and optic pathway glioma. Horm Res Paediatr. 2017;87:179–88. - DOI